症狀檢驗報告

老年免疫

英文名稱:Immune Elderly

共有幾筆評級
2 筆
資料日期
2026-06-09

檢驗結果

逐筆明細

C薄弱證據實證評級速查

保健成分 × 適應症

比菲德氏菌 BB536 × 老年免疫

55
分(滿分 100)

白話說:證據還很薄弱,不足以當成有效的療法。

發布狀態:可參考,但附帶但書

部分研究有廠商利益台灣有獨立規範
各國衛生機關怎麼說
  • 第三方營養資料庫(國際)
    展開原文引用
    「Probiotics (Also known as: probiotic) are microorganisms that can have a positive effect on health. Examine catalogs evidence at the umbrella 'Probiotics' level rather than for individual strains such」
  • 美國 FDA 態度:支持
    展開原文引用
    「GRN No. 877 — Bifidobacterium longum BB536. Intended use: ingredient in term infant formula at a level of 1 x 10^8 CFU per gram of product. FDA closure date: December 26, 2019. FDA letter: 'FDA has no questions' regarding the safety of Bifidobacterium longum BB536 when used as described in the notice. (Earlier GRN 268 covered use in conventional foods/beverages.)」
  • 歐盟 EFSA 態度:持保留
    展開原文引用
    「Scientific Opinion on the substantiation of health claims related to Bifidobacterium longum BB536 and improvement of bowel regularity (ID 3004), normal resistance to cedar pollen allergens (ID 3006), and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 3005) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. Conclusion: Bifidobacterium longum BB536 does not improve…」

評級由多源健康證據引擎彙整(FDA/EFSA/NHS/TFDA/WHO/PubMed/NIH ODS 等多個官方與權威來源)。 產製日期 2026-06-09 · 版本 v7。本評級僅供衛教參考,不取代醫師診斷與處方。 · 查看此成分的完整評級 · 證據資料庫原始頁面

C薄弱證據實證評級速查

保健成分 × 適應症

副乾酪乳桿菌 K71/LP33 × 老年免疫

46
分(滿分 100)

白話說:證據還很薄弱,不足以當成有效的療法。

發布狀態:可參考,但附帶但書

部分研究有廠商利益留意藥物交互作用
各國衛生機關怎麼說
  • 英國 NHS 態度:未涵蓋
    展開原文引用
    「There's some evidence that probiotics may be helpful in some cases, such as helping to ease some symptoms of irritable bowel syndrome (IBS). But there's little evidence to support many health claims made about them. For example, there's no evidence to suggest that probiotics can help treat eczema.」
  • 美國 NIH 膳食補充劑辦公室 態度:持保留
    展開原文引用
    「A review of 23 studies (1,919 participants) in which probiotics were tested for treating allergic rhinitis found some evidence that they may be helpful for improving symptoms and quality of life... because the studies tested different probiotics and measured different effects, no recommendations about the use of probiotics could be made.」
  • PubMed PMID 36001877· 2022 · Cochrane Review · n=6950
    展開原文引用
    「Probiotics for preventing acute upper respiratory tract infections」

評級由多源健康證據引擎彙整(FDA/EFSA/NHS/TFDA/WHO/PubMed/NIH ODS 等多個官方與權威來源)。 產製日期 2026-06-09 · 版本 v10。本評級僅供衛教參考,不取代醫師診斷與處方。 · 查看此成分的完整評級 · 證據資料庫原始頁面